-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
-
Summary
-
Orion Biotech Opportunities Corp. quarterly Assets, Current history and growth rate from Q2 2021 to Q4 2022.
- Orion Biotech Opportunities Corp. Assets, Current for the quarter ending December 31, 2022 was $439K, a 67.5% decline year-over-year.
Assets, Current, Quarterly (USD)
Assets, Current, YoY Quarterly Growth (%)